Di-l-cysteaminehydrochloridetetranitrosyldiiron(I) 6a. To
a
The solution changed from red to green. Then a solution of
trishydroxymethylphosphine (0.036 g, 0.290 mmol) in 3 ml of
nitromethane was added dropwise. To precipitate 11, a large
portion (20 ml) of cold toluene was added. The green product
was filtered off and dried under vacuum. Due to the instability of
11 at room temperature a correct elemental analysis could not be
obtained. Yield: 85 mg (63%). IR (nitromethane, −10 ◦C, CaF2):
m/cm−1 = 1927 (w, NO); 1833 (vs, NO). 1H NMR (nitromethane-
d3): d 4.73 (s, 6H, CH2OH). 13C NMR (nitromethane-d3): d 55.0
solution of dicarbonyldinitrosyliron (0.100 g, 0.582 mmol) in
30 ml of THF was added cysteamine hydrochloride (0.066 g,
0.582 mmol). The mixture was refluxed overnight and the pre-
cipitate was filtered off and dried under vacuum to give 6 as an
ochre precipitate. Yield: 11 mg (40%). Found: C, 13.14; H, 3.02; N,
17.05%. C4H14Cl2Fe2N6O4S2, S(CH2)2NH3Cl required: C, 12.66;
H, 3.68; N, 17.21%. IR (Nujol): m/cm−1 = 1754 (m, NO); 1753
1
(s, NO). H NMR (water-d2): d 1.77 (s, 2H, CH2S); 3.4 (m, 2H,
CH2NH3Cl). 13C NMR (water-d2): d 22.8 (s, 2H, SCH2); 65.7 (s,
(d, J = 50 Hz, CH2OH). 19F NMR (nitromethane-d3): d −72.0
1
2H, CH2NH3Cl).
(d, 1J = 714 Hz, 6F, PF6). 31P NMR (nitromethane-d3): d −144,0
(hept., 1J = 715 Hz, PF6); 46,0 (s, P(CH2OH)3).
Di-l-cysteaminehydroiodidetetranitrosyldiiron(I) 6b. A mix-
ture of di-l-iodotetranitrosyldiiron [Fe(NO)2I]2 (0.100 g,
0.205 mmol) and cysteine (0.016 g, 0.205 mmol) in 20 ml of THF
was stirred at room temperature for 18 h. The brown precipitate
was filtered off and washed several times with ether and dried
under vacuum to give 7. Yield: 124 mg (95%). Found: C, 12.63; H,
2.97; N, 12.06%. C4H14I2Fe2N6O4S2, required: C, 13.53; H, 2.81;
N, 11.83%. IR (Nujol): m/cm−1 = 1782 (s, NO); 1715 (s, NO);
Trinitrosyl(tris(hydroxymethyl)phosphine)iron(II) tetrafluorobo-
rate 12. The same procedure as for 11 was used to synthesise the
trinitrosyl(trishydroxymethylphosphine)iron(II) tetrafluoroborate
12, and the hexafluoroantimonate 13, using nitrosoniumtetraflu-
oroborate for 12 and nitrosoniumhexafluoroantimonate for 13
as nitrosylating agents. Due to the instability of 12 at room
temperature a correct elemental analysis could not be obtained.
1464 (m, NH3). 1H NMR (water-d2): d 3.3 (m, 4H, CH2CH2). 13
C
Yield: 74 mg (63%). IR (nitromethane, −10 ◦C, CaF2): m/cm−1
=
NMR (water-d2): d 37.9 (d, 1J = 8 Hz, SCH2); 39.5 (d, 1J = 4 Hz,
1927 (w, NO); 1835 (vs, NO). 1H NMR (nitromethane-d3): d 4.79 (s,
6H, CH2OH). 13C NMR (nitromethane-d3): d 57.0 (sb, CH2OH).
31P NMR (nitromethane-d3): d 47.0 (s, P(CH2OH)3). 19F NMR
(nitromethane-d3): d −144.0 (s, BF4).
CH2NH2).
Di-l-cysteineethanoatetetranitrosyldiiron(I) 8. To a solution of
dicarbonyldinitrosyliron (0.100 g, 0.582 mmol) in 40 ml of THF
the L-cysteine ethyl ester hydrochloride (0.307 g, 0.582 mmol)
was added. The mixture was stirred at room temperature for 3
d. The solution was evaporated under vacuum to give 8 as a deep
green product. Yield: 181 mg (81%). Found: C, 23.00; H, 4.02.
Trinitrosyl(tris(hydroxymethyl)phosphine)iron(II) hexafluoroan-
timonate 13. Due to the instability of 13 at room temperature
a correct elemental analysis could not be obtained. Yield: 34 mg
(21%). IR (nitromethane, −10 ◦C, CaF2): m/cm−1 = 1927 (w, NO);
1835 (s, NO). 1H NMR (nitromethane-d3): d 4.82 (s, 6H, CH2OH).
31P NMR (nitromethane-d3): d 46.0 (s, P(CH2OH)3). 13C NMR
(nitromethane-d3): d 57.5.
C10H20Fe2N6O8S2 required: C, 22.66; H, 4.15. IR (Nujol): m/cm−1
=
1755 (m, NO); 1711 (s, CO(O)Et); 1595 (w, NH2). 1H NMR (THF-
d8): d 0.88 (m, 2H, CH2CH3); 1.35 (m, 3H, CH2CH3); 4.39 (m, 3H,
CH2CH). 13C NMR (THF-d8): d 14.2 (s, S–CH2); 23.1 (s, NH2CH);
26.3 (s, OCH2CH3); 34.9 (s, OCH2CH3); 64.1 (s, CO(OCH2CH3).
Crystal data are given in Tables 6 and 7.
CCDC reference numbers 610298–610305.
Di-l-(pyrimidine-2-thionate)tetranitrosyldiiron(I) 9. To a solu-
tion of dicarbonyldinitrosyliron (0.100 g, 0.582 mmol) in 40 ml
of THF was added pyrimidine-2-thiol (0.065 g, 0.582 mmol). The
solution is refluxed for 16 h. Removal of the solvent under vacuum
gave 9 as a black solid. Yield: 132 mg (50%). Found: C, 21.36; H,
1.40; N, 24.40%. C8H6Fe2N8O4S2 requires: C, 21.07; H, 1.75; N,
For crystallographic data in CIF or other electronic format see
DOI: 10.1039/b702461d
References
1 A. R. F. Furchgott and J. V. Zawadzki, Nature, 1980, 288, 373–376;
S. Moncada, R. M. J. Palmer and E. A. Higgs, Pharm. Rev., 1991,
43, 109–141; R. F. Furchgott, Vasodilation: Vasular Smooth Muscle,
Peptides, and Endothelium, ed. P. M. Vanhoutte, Raven Press, New
York, 1988, pp. 401–414; S. Moncada, R. M. J. Palmer and E. A.
Higgs, Pharm. Rev., 1991, 43, 109–141; N. Miki, Y. Kawabe and K.
Kuriyama, Biochem. Biophys. Res. Commun., 1977, 75(4), 851–856.
2 R. F. Furchgott and J. V. Zawadzki, Nature, 1980, 288, 373–376.
3 F. Murad, Angew. Chem., Int. Ed., 1999, 38, 1856–1868; R. F.
Furchgott, Angew. Chem., Int. Ed., 1999, 38, 1870–1880; L.-J. Ignarro,
Angew. Chem., Int. Ed., 1999, 38, 1882–1892.
4 A. R. Butler and C. Glidewell, Chem. Soc. Rev., 1987, 16, 361–380;
E. A. Kowaluk, P. Seth and H.-L. Fung, J. Pharmacol. Exp. Ther.,
1992, 262(3), 916–922.
5 P. G. Wang, M. Xian, X. Tang, X. Wu, Z. Wen, T. Cai and A. J. Janczuk,
Chem. Rev., 2002, 102, 1091–1134.
1
24.57%. IR (THF): m/cm−1 = 1794 (m, NO); 1759 (s, NO). H
NMR (THF-d8): d 7.14 (s, 1H, CHpyr.); 8.55 (s, 2H, 2CNCHpyr.).
13C NMR (THF-d8): d 121.0 (s, Cpyr.HCH); 158.5 (s, 2CpyrN); 174.0
(s, Cpyr.S).
Dinitrosyl(pyrimidine-2-thionate)iodoiron(0) 10. A solution of
[Fe(NO)2I]2 (0.100 g, 0.205 mmol) and pyrimidine-2-thiol (0.023 g,
0.205 mmol) in 40 ml of THF was stirred for 3 h at room
temperature. Recrystallization from THF–ether gave 10 as a black
solid. Yield: 79 mg (67%). Found: C, 18.44; H, 2.10; N, 14.32%.
C8H6IFe2N8O4S2 required: C, 18.39; H, 2.29; N, 14.29%. IR
(THF): m/cm−1 = 1790 (m, NO); 1722 (s, NO). 1H NMR (THF-
d8): d 3.4 (m, 1H, Hpyr.CH); 3.58 (s, 2H, Hpyr.CHN). 13C NMR
(THF-d8): d 15.6 (s, 2C, CHN); 66.3 (s, 2C, CH2; C–S).
6 D. J. Stuehr, S. S. Gross, I. Sakuma, R. Levi and C. F. Nathan, J. Exp.
Med., 1989, 169, 1011–1020; Pellat, Y. Henry and J.-C. Drapier, Nitric
oxide from L-arginine: a bioregulatory system, ed. S. Moncada and
E. A. Higgs, Elsevier, Amsterdam, 1990, pp. 281–289.
7 M. E. Murphy and H. Sies, Proc. Natl. Acad. Sci. USA, 1991, 88,
10860–10864.
Trinitrosyl(tris(hydroxymethyl)phosphine)iron(II)
hexafluo-
rophosphate 11. To
a solution of dicarbonyldinitrosyliron
(0.050 g, 0.290 mmol) in 3 ml of nitromethane at −30◦
C
8 K. Shibuki, Neurosci. Res., 1990, 9, 69–76; T. Malinski and Z. Taha,
Nature, 1992, 358, 676–8.
was added NOPF6 (0.050 g, 0.290 mmol) in small portions.
3570 | Dalton Trans., 2007, 3562–3571
This journal is
The Royal Society of Chemistry 2007
©